Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis.

However, there may be significant fluctuation of symptoms, onset of relapses, and accrual of disability in between clinic visits that are not well measured by this clinical visit schedule.

also in 13,097 other papers